Dr Andrew Conn
Consultant medical oncologist
I am a consultant medical oncologist specialising in the non-surgical management of patients with bowel cancer, lung cancer and mesothelioma. This includes the use of chemotherapy as well as the latest targeted treatments.
I trained in medical oncology at Nottingham University Hospitals NHS Trust and during this time undertook three years of laboratory based research as a Cancer Research UK Clinical Fellow.
For my research into the development of a vaccine to treat colorectal cancer I was awarded a Doctor of Philosophy degree by the University of Nottingham. In 2007 I was appointed to the post of Consultant Medical Oncologist at Bradford Teaching Hospitals NHS Foundation Trust and Airedale NHS Foundation Trust.
I take pride in offering each patient with bowel cancer, lung cancer or mesothelioma a personalised treatment plan that guarantees access to the most effective treatments. In addition to chemotherapy this also includes the use of targeted therapies such as Avastin (bevacizumab), Erbitux (cetuximab) and Zaltrap (aflibercept) in bowel cancer and Xalkori (crizotinib), Iressa (gefitinib) and Tarceva (erlotinib) in lung cancer. This commitment to an individualised approach to patient care ensures the best possible outcomes for my patients.
Some of the principal treatments carried out by Dr Andrew Conn at Spire include:
Spire Leeds Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
Consultant medical oncologist, Bradford Teaching Hospitals Trust and Airedale NHS Foundation Trust
I grew up in Northern Ireland before studying medicine at the University of Nottingham. I am married with one daughter who has recently started Grammar School. My main leisure interest is cycling and I am an active member of Ilkley Cycle Club with whom I make frequent rides into the Yorkshire Dales.